Dr Samuel Hutchinson, DO in Mesa, AZ - Medicare Psychiatry & Neurology

Dr Samuel Hutchinson, DO is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Mesa, Arizona. His current practice location is 4135 S Power Rd, Mesa, Arizona. You can reach out to his office (for appointments etc.) via phone at (480) 397-2830.

Dr Samuel Hutchinson is licensed to practice in Nebraska (license number 8008) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1033630934.

Contact Information

	Dr Samuel Hutchinson, DO
	4135 S Power Rd, Mesa, AZ 85212-3624
	(480) 397-2830
	Not Available

Physician's Profile

Full Name	Dr Samuel Hutchinson
Gender	Male
Speciality	Psychiatry & Neurology - Psychiatry
Location	4135 S Power Rd, Mesa, Arizona
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033630934
Provider Enumeration Date: 06/29/2017
Last Update Date: 11/18/2022

Medicare PECOS Information:

PECOS PAC ID: 6103163365
Enrollment ID: I20190125000480

Medical Identifiers

Medical identifiers for Dr Samuel Hutchinson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033630934	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	8008 (Nebraska)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Samuel Hutchinson allows following entities to bill medicare on his behalf.

Entity Name	Heartland Family Service
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1891788048 PECOS PAC ID: 7315833506 Enrollment ID: O20040225000174

News Archive

Researchers examine specifications for mass acceptance of contact-tracing apps

Coronavirus tracing applications for the detection of infection chains are currently being developed and made available across the world.

Improvements in cancer survival in Northern Ireland

There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR), launched at Queen's today.

Treatment score aids decision-making in unruptured intracranial aneurysm management

Researchers have developed an unruptured intracranial aneurysm treatment score model that arms clinicians with consensus from a group of specialists on how to manage individuals with the condition.

Mylan receives final FDA approvals for generic Lamictal tablets

Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Applications (ANDAs) for Lamotrigine Tablets.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Samuel Hutchinson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Samuel Hutchinson, DO 4135 S Power Rd Ste 103, Mesa, AZ 85212-3625 Ph: (480) 397-2830	Dr Samuel Hutchinson, DO 4135 S Power Rd, Mesa, AZ 85212-3624 Ph: (480) 397-2830

News Archive

Researchers examine specifications for mass acceptance of contact-tracing apps

Coronavirus tracing applications for the detection of infection chains are currently being developed and made available across the world.

Improvements in cancer survival in Northern Ireland

There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR), launched at Queen's today.

Treatment score aids decision-making in unruptured intracranial aneurysm management

Researchers have developed an unruptured intracranial aneurysm treatment score model that arms clinicians with consensus from a group of specialists on how to manage individuals with the condition.

Mylan receives final FDA approvals for generic Lamictal tablets

Psychiatry & Neurology Doctors in Mesa, AZ

Amol Rohit Patel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2028
Dr. Kate Gillpatrick, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000
Nancy L Vander Veer, PSYD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 602-344-2002 Fax: 480-649-0783
Dr. Yaniv Simon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2026 Fax: 480-344-0219
Payam M Sadr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000 Fax: 480-649-0783
Troy Michael Fulton, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3707 E Southern Ave, Mesa, AZ 85206 Phone: 480-509-7738

Dr Samuel Hutchinson, DO - Medicare Psychiatry & Neurology in Mesa, AZ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Researchers examine specifications for mass acceptance of contact-tracing apps

Improvements in cancer survival in Northern Ireland

Treatment score aids decision-making in unruptured intracranial aneurysm management

Mylan receives final FDA approvals for generic Lamictal tablets

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Researchers examine specifications for mass acceptance of contact-tracing apps

Improvements in cancer survival in Northern Ireland

Treatment score aids decision-making in unruptured intracranial aneurysm management

Mylan receives final FDA approvals for generic Lamictal tablets

Psychiatry & Neurology Doctors in Mesa, AZ